Divergent mutational processes distinguish hypoxic and normoxic tumours
Vinayak Bhandari(Ontario Institute for Cancer Research), Gary D. Bader(University of Toronto), Shun‐ichi Ariizumi(Tokyo Women's Medical University), Philip Awadalla(Ontario Institute for Cancer Research), Paul C. Boutros(University of California, Los Angeles), Axel Aretz, Yasuhito Arai, Robert G. Bristow(Princess Margaret Cancer Centre), Ole Ammerpohl(Christian-Albrechts-Universität zu Kiel), Joshua Armenia(AstraZeneca (United Kingdom)), Hikmat Al‐Ahmadie(Unknown), Federico Abascal(Wellcome Sanger Institute), Yeng Ang(The University of Texas MD Anderson Cancer Center), Eva G. Álvarez(Universidade de Santiago de Compostela), Fátima Al‐Shahrour(Broad Institute), Lauri A. Aaltonen(Varsinais-Suomen Sairaanhoitopiiri), Kathryn Alsop(Peter MacCallum Cancer Centre), Kadir C. Akdemir, Hiroshi Aikata(Hiroshima Prefectural Hospital), Elizabeth L. Appelbaum, Brice Aminou, Fernanda Amary(Royal National Orthopaedic Hospital), Sultan T. Al‐Sedairy, Pavana Anur, Marta Aymerich(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Adam Abeshouse(Memorial Sloan Kettering Cancer Center), Sietse Aukema(University Medical Center Groningen), Nishant Agrawal(University of Chicago), Miriam R. R. Aure(Oslo University Hospital), Davide Antonello, Rehan Akbani(The University of Texas MD Anderson Cancer Center), Samirkumar B. Amin(Jackson Laboratory), Adrian Ally(The University of Texas MD Anderson Cancer Center), J. Todd Auman(The University of Texas MD Anderson Cancer Center), Kenneth Aldape(National Institutes of Health), Matthew J. Anderson(National Cancer Institute), Constance H. Li(Duke-NUS Medical School), Laurent Arnould(Los Alamos National Laboratory), Yassen Assenov(Max Planck Institute for Informatics), Samuel Aparício(BC Cancer Agency), Monique Albert(Ontario Institute for Cancer Research), Keun Soo Ahn(Keimyung University Dongsan Medical Center), Gurnit Atwal(Ontario Institute for Cancer Research), Ludmil B. Alexandrov(UC San Diego Health System), Malik Alawi(Universität Hamburg), L. Sylvia(University Hospitals of Cleveland), David J. Adams(Wellcome Sanger Institute), Koji Arihiro(Hiroshima University Hospital), Sung-Min Ahn, Hiroyuki Aburatani(The University of Tokyo)
Cited by 143
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
The Somatic Genomic Landscape of Glioblastoma
|Cell|2013|5.2k
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
|Science Translational Medicine|2014|5.1k
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
|Nature Genetics|2019|4.4k
The repertoire of mutational signatures in human cancer
|Nature|2020|3.8k